Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prelude Therapeutics (PRLD) Asset Utilization Ratio (2024 - 2025)

Prelude Therapeutics' Asset Utilization Ratio history spans 2 years, with the latest figure at 0.06 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 46.61% year-over-year to 0.06; the TTM value through Dec 2025 reached 0.06, up 46.61%, while the annual FY2025 figure was 0.08, N/A changed from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.06 at Prelude Therapeutics, down from 0.1 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.1 in Q3 2025 and bottomed at 0.04 in Q4 2024.